ConductScience.org, home

Paper498131

Development of an agar-methyl cellulose clonogenic assay for cells in transitional cell carcinoma of the human bladder.

Buick RN and 5 others. Cancer Res, 1979. Cited by 96 papers, by iCite.

Cite this record

ConductScience Library. Development of an agar-methyl cellulose clonogenic assay for cells in transitional cell carcinoma of the human bladder. Papers, record 498131. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/498131

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Development of an agar-methyl cellulose clonogenic assay for cells in transitional cell carcinoma of the human bladder.
PubMed
Journal
Cancer Res
PubMed
Year
1979
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
96
iCite
Relative citation ratio, by iCite
3.79
iCite
Revised in PubMed
2006-11-15
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Buick RNR N
2Stanisic THT H
3Fry SES E
4Salmon SES E
5Trent JMJ M
6Krasovich PP

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Carcinoma, Transitional CellMajor topic
Clone CellsMajor topic
Urinary Bladder NeoplasmsMajor topic
Agar
Aged
Cell Division
Chromosome Aberrations
Female
Humans
Male
Methods
Methylcellulose
Microscopy, Electron
Middle Aged

Source PubMed

Download CSV of topics

Cited by20

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 96 citations.

PMIDTitleJournalYearIn PapersSource
23760992Targeted therapy aimed at cancer stem cells: Wilms' tumor as an example.Pediatr Nephrol2014https://conductscience.org/library/papers/23760992PubMed
20657288Cancer stem cells in bladder cancer: a revisited and evolving concept.Curr Opin Urol2010https://conductscience.org/library/papers/20657288PubMed
7974916Growth characteristics of early passage cell lines compared with established TCC bladder lines.Urol Res1994https://conductscience.org/library/papers/7974916PubMed
7459227A comparison of human tumour-cell clonogenicity in methylcellulose and agar culture.Br J Cancer1980https://conductscience.org/library/papers/7459227PubMed
7426298Effect of host-cell interactions on clonogenic carcinoma cells in human malignant effusions.Br J Cancer1980https://conductscience.org/library/papers/7426298PubMed
7340985A comparative assessment of the in vitro effects of drugs on cells by means of colony assays or flow microfluorimetry.Cancer Chemother Pharmacol1981https://conductscience.org/library/papers/7340985PubMed
7318144Quantitative association between the in vitro human tumor stem cell assay and clinical response to cancer chemotherapy.Cancer Chemother Pharmacol1981https://conductscience.org/library/papers/7318144PubMed
7318143Human tumor clonogenic assays. An overview.Cancer Chemother Pharmacol1981https://conductscience.org/library/papers/7318143PubMed
7032739The soft agar clonogenicity and characterization of cells obtained from human solid tumors by mechanical and enzymatic means.Cancer Chemother Pharmacol1981https://conductscience.org/library/papers/7032739PubMed
7019254Role of laboratory chemosensitivity testing in the selection of cancer chemotherapy for individual patients.J Clin Pathol1981https://conductscience.org/library/papers/7019254PubMed
6873974The proliferation of human tumor cell lines in the presence of different agars, agaroses, and methyl cellulose.In Vitro1983https://conductscience.org/library/papers/6873974PubMed
6859216Altered growth patterns in vitro of human papillary transitional carcinoma cells.Am J Pathol1983https://conductscience.org/library/papers/6859216PubMed
6381376The human tumor cloning assay in cancer drug development. A review.Invest New Drugs1983https://conductscience.org/library/papers/6381376PubMed
6364821Immunoperoxidase staining of early human melanoma colonies with monoclonal antibodies. A new method for in vitro antigenic-morphologic correlation.Am J Pathol1984https://conductscience.org/library/papers/6364821PubMed
6357700Prediction of response to cancer chemotherapy.Drugs1983https://conductscience.org/library/papers/6357700PubMed
6339514Correlation of tumor-cell growth in four semisolid systems.J Cancer Res Clin Oncol1983https://conductscience.org/library/papers/6339514PubMed
6324933Tumor cell colonies in bone marrow cultures from patients with small cell carcinoma of the lung.Blut1984https://conductscience.org/library/papers/6324933PubMed
4019570Cloning ovarian carcinoma cells in an agar double layer versus a methylcellulose monolayer system. A comparison of two methods.J Cancer Res Clin Oncol1985https://conductscience.org/library/papers/4019570PubMed
3444392Cytotoxic activity of the thioether phospholipid analogue BM 41.440 in primary human tumor cultures.Lipids1987https://conductscience.org/library/papers/3444392PubMed
2474549Inhibited methionine incorporation in human squamous carcinomas of the oral cavity as a measure for response to 5-fluorouracil.J Cancer Res Clin Oncol1989https://conductscience.org/library/papers/2474549PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/498131

GET https://conductscience.org/api/papers/v1/498131/authors